Ect and pharmacotherapy
WebElectroconvulsive therapy was commonly used as a first-line antidepressant treatment, but in recent decades medication resistance has become its primary indication. 1 There is substantial evidence that the … WebContinuation and maintenance ECT, in combination with pharmacotherapy, have been successfully used in preventing relapse and recurrence. Gradual tapering off acute …
Ect and pharmacotherapy
Did you know?
WebObjective: This study assessed the incidence, severity, and course of expressed suicidal intent in depressed patients who were treated with ECT. The data are from the first phase of an ongoing, collaborative multicenter study, the overall aim of which was to compare continuation ECT with pharmacotherapy in the prevention of relapse after a successful … WebFeb 20, 2024 · Although electroconvulsive therapy (ECT) is, along with antidepressants and psychotherapy, one of the three major treatments of depression, it is still considered as the last resort for depressed patients. ... The PRIDE/CORE group was established to investigate whether combined pharmacotherapy and ECT, personalized according to …
WebJun 27, 2024 · The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 32, 244–54. CrossRef Google Scholar PubMed. Sackeim, H. A., Prudic, J., Nobler, M. S., et al. ( 2008 ). Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimulation 1, 71 … WebElectroconvulsive therapy (ECT) remains the most effective therapy in treatment-resistant depression. However, the safety of ECT has been consistently questioned, particularly among elderly patients. We assessed the efficacy and safety of ECT in patients before and after 65 years old. The study was conducted between 2015 and 2024 and included 91 …
WebSep 1, 2016 · The results of a two-part study of using ultrabrief ECT (where brain stimulation is delivered using shorter electrical pulses) now suggest that treating geriatric patients with ECT and pharmacotherapy may lead to more rapid and sustained improvements in depressive symptoms than pharmacotherapy alone, with few adverse effects on cognition. WebNeurocognitive outcome did not differ between STABLE plus pharmacotherapy versus pharmacotherapy alone over the 6-month continuation treatment phase. These findings support the safety of RUL-UB ECT in combination with pharmacotherapy in the prolonging of remission in late-life depression.
WebJul 10, 2024 · ECT is not prescribed for every patient with depression for several reasons: It is time consuming, expensive, uncomfortable from a side-effect standpoint, and not readily available in many locales. In this article, I will review some variables that help predict ECT outcomes and present an algorithm to assist psychiatrists in deciding which ...
WebPatients who were treated with adjunctive mood stabilizers as maintenance pharmacotherapy after the response to the acute ECT course were at a lower risk of relapse than were those treated without mood stabilizers (hazard ratio: 0.257; P=0.047).Conclusion: Our study on the recurrence of schizophrenia after a response to … stats youngWebCurrent practice for preventing a relapse is to taper ECT after an initial course and continue treatment with pharmacotherapy, maintenance ECT, or both, guided by the number and severity of prior ... stats2scoreWebMar 13, 2024 · A retrospective controlled study into memory complaints reported by depressed patients after treatment with electroconvulsive therapy and … stats.linregress pythonWebObjective: The primary aim of the study was to test the hypothesis that relapse prevention with continuation electroconvulsive therapy (ECT) plus … stats.fill_commodities_household sims 4WebAug 1, 2024 · It is now estimated that nearly 85% of patients relapse if ECT is followed by placebo and that approximately 50% will retain benefit for … stats year 2Web2 days ago · Patients who received maintenance ECT plus pharmacotherapy after acute ECT had a 54% lower risk of recurrence and relapse at 12 months than did those who received pharmacotherapy alone . Moreover, in older patients with psychotic depression, the 2-year relapse rate was only 8% with nortriptyline plus maintenance ECT and 62% … stats4everyoneWebKellner C, Knapp R and Petrides G. (2006) Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Archives of General Psychiatry 63: 1337-1344. Kellner CH. (2010) ECT Today: The Good It Can Do. … stats24 tippfootball